Picture of Japan Tissue Engineering Co logo

7774 Japan Tissue Engineering Co Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Annual cashflow statement for Japan Tissue Engineering Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-230-463-494-725147
Depreciation
Non-Cash Items6.791.8-10.9-0.4230
Unusual Items
Other Non-Cash Items
Changes in Working Capital14.3-66.8155-28.2-36.9
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Taxes Payable
Other Operating Cash Flow
Cash from Operating Activities-84.6-400-225-623274
Capital Expenditures-91.2-74.4-117-176-273
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items3002000.7511,30131
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities209126-1161,125-242
Financing Cash Flow Items-0.001
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3.19-1.3-0.823-0.803-0.134
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash121-275-34350131.8